Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mucociliary clearance apparatus is the primary mechanical defense of the lung, composed of airway epithelial cilia, mucus secreted by goblet and submucosal cells, and the airway surface liquid. Ciliary beating transports the mucus layer containing trapped particles and pathogens upwards toward the pharynx for elimination. When mucus accumulates or thickens, cough and airflow assist clearance. Dysfunction of any component impairs mucus transport, leading to airway obstruction, increased infection risk, and chronic lung disease. Therapies target mucus hydration, viscosity, and ciliary function to facilitate “phlegm resolution”—the restoration of airway patency by removal of excess or abnormal mucus.
Mucolytics reduce mucus viscosity and promote clearance. Hydrators increase airway surface liquid hydration. Bronchodilators improve airway patency. Mechanical physiotherapy enhances airflow/shear for clearance.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucociliary clearance apparatus (MCC).